| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $70.4M | -70.6% | -16.6% |
| Cost of Revenue | $21.5M | +40.3% | -64.5% |
| R&D Expense | $98.3M | +24.0% | +12.7% |
| SG&A Expense | $31.7M | -27.4% | -55.3% |
| Operating Income | -$178.0M | -276.1% | -32.8% |
| Interest Expense | $3.0M | +12.2% | +13.3% |
| Pre-tax Income | -$203.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $268.0M | +5.6% | -53.3% |
| Short-term Investments | $494.9M | +38.0% | +47.3% |
| Inventory | $13.5M | +31.9% | +56.4% |
| Current Assets | $974.6M | +6.0% | -11.7% |
| Total Assets | $1.18B | -11.7% | -31.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$205.2M | — | — |
| Capital Expenditures | $3.5M | — | — |
| Investing Cash Flow | -$98.8M | — | — |
| Financing Cash Flow | $34.3M | — | — |
| Free Cash Flow | -$208.6M | — | — |
| -289.0% |
| -66.0% |
| Income Tax | -$657K | -169.5% | +36.3% |
| Net Income | -$202.4M | -290.0% | -66.8% |
| EPS (Basic) | -$1.25 | -289.4% | -64.5% |
| EPS (Diluted) | -$1.25 | -301.6% | -64.5% |
| $429.9M |
| +10.5% |
| -63.6% |
| Total Liabilities | $1.34B | +2.9% | -40.3% |
| Stockholders' Equity | -$156.7M | -516.4% | +70.2% |